CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 4 Option exercise Director acquired 7,680 shares (option exercise)
- 4 Option exercise Director acquired 9,985 shares (option exercise)
- 4 Option exercise Director acquired 9,524 shares (option exercise)
- 4 Option exercise Director acquired 8,602 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Executive or director change
- 4 Option exercise Director acquired 333,333 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy President & CEO bought 12,121 shares at $4.12 ($49,878)
- 4 Open-market buy Director bought 100,000 shares at $4.12 ($411,500)
- 4 Open-market buy Director bought 145,450 shares at $4.12 ($598,527)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- POS AM Other Post-effective Amendment for Registration Statement
- FWP Offering Free Writing Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
Page 31 of 53 · 1,057 filings